2-Apr-2026
Buy Rating on Valuation and Earnings Power as Market Overreacts to Concentrated Slowdown Risks
TipRanks (Sun, 5-Apr 12:05 PM ET)
Phreesia Earnings Call: Profit Breakthrough, Growth Reset
TipRanks (Sat, 4-Apr 8:30 PM ET)
PHR Investors Have Opportunity to Join Phreesia, Inc. Fraud Investigation with the Schall Law Firm
Business Wire (Fri, 3-Apr 3:34 PM ET)
Major Investor Quietly Doubles Down on Phreesia With Multimillion-Dollar Buy-In
TipRanks (Thu, 2-Apr 10:05 PM ET)
RBC Capital Keeps Their Buy Rating on Phreesia (PHR)
TipRanks (Thu, 2-Apr 9:50 PM ET)
Integration Risks Cloud Phreesia’s AccessOne Deal, Threatening Synergies and Share Performance
TipRanks (Thu, 2-Apr 2:01 AM ET)
FuboTV and Yext are the most oversold among U.S. small-cap stocks
Seeking Alpha News (Wed, 1-Apr 1:53 PM ET)
Phreesia Announces Fourth Quarter Fiscal 2026 Results
Business Wire (Mon, 30-Mar 4:03 PM ET)
Phreesia Named One of Becker's Top Places to Work in Healthcare
Business Wire (Tue, 24-Mar 4:09 PM ET)
Market Chameleon (Fri, 20-Mar 6:04 AM ET)
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Phreesia trades on the NYSE stock market under the symbol PHR.
As of April 2, 2026, PHR stock price declined to $8.37 with 3,199,373 million shares trading.
PHR has a beta of 0.67, meaning it tends to be less sensitive to market movements. PHR has a correlation of 0.05 to the broad based SPY ETF.
PHR has a market cap of $504.60 million. This is considered a Small Cap stock.
Last quarter Phreesia reported $127 million in Revenue and $.02 earnings per share. This beat revenue expectation by $543,232 and missed earnings estimates by -$.21.
In the last 3 years, PHR traded as high as $34.98 and as low as $7.77.
The top ETF exchange traded funds that PHR belongs to (by Net Assets): VTI, IWM, VB, VXF, VBK.
PHR has underperformed the market in the last year with a price return of -68.0% while the SPY ETF gained +17.5%. PHR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.7% and -28.9%, respectively, while the SPY returned -3.7% and -0.1%, respectively.
PHR support price is $8.09 and resistance is $8.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHR shares will trade within this expected range on the day.